To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)

Condition:   AsthmaIntervention:   Drug: MK0476, montelukast sodium / Duration of Treatment: 12 WeeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials